MAPK3 and drug-induced dyskinesia: On the other hand, others have reported that the sensitized ERK1/2 activation observed in dopamine depleted animals may be reduced after chronic l-DOPA treatment 21,50,77,78 and that ERK1/2 attenuation is associated with reduced dyskinesia severity50,78.